Results 181 to 190 of about 3,258,123 (297)

Feline oral squamous cell carcinoma and Felis catus papillomavirus: is it time to walk the path of human oncology?

Frontiers in Veterinary Science, 2023
Gennaro Altamura, Giuseppe Borzacchiello
doaj   +1 more source

Nice Restrictiveness Compared to the Market Authorization In Oncology And Non-Oncology Reviews [PDF]

Value in Health, 2014
Jaksa, A., Westbrook, L., Rubinstein, E., Daniel, K., Ho, Y.S.   +4 more
openaire   +2 more sources

Editorial: Canine melanoma in comparative oncology: Translate research advances to develop new diagnostic and therapeutic options. [PDF]

Front Vet Sci, 2022
Bongiovanni L, Brachelente C, Dow S, Bergman PJ.   +3 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Extracellular Matrix Remodeling as a Mechanobiological Driver of Breast Cancer Aggressiveness: Comparative Oncology, Multi-Omics, and Artificial Intelligence Perspectives. [PDF]

Biology (Basel)
Parra JPRLL, Abuná RPF, Garcia MHH, Barbalho SM, Miglino MA.   +4 more
europepmc   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source

Serum untargeted metabolomics reveals key pathways in feline mammary carcinoma for comparative oncology. [PDF]

Metabolomics
de Sá HC, Rodrigues GM, de Carvalho VMP, Silva LP, Kato MJ, Estrela-Lima A, Canuto GAB.   +6 more
europepmc   +1 more source

Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations. [PDF]

JNCI Cancer Spectr, 2022
McCaw ZR, Kim DH, Wei LJ.
europepmc   +1 more source

Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling

Molecular Oncology, EarlyView.
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan, Beatriz Martín‐Gracia, Eva Bassols‐Citores, Krizia Sagini, Maria K. Andersen, Tuula A. Nyman, May‐Britt Tessem, Morten B. Rye, Alicia Llorente   +8 more
wiley   +1 more source

Comparative Oncology: The Veterinary Contribution [PDF]

Proceedings of the Royal Society of Medicine, 1976
openaire   +2 more sources